ヘパリンナトリウム注射の世界市場2020-2026:1,000USP単位/mL、5,000USP単位/mL、10,000USP単位/mL

QYResearchが発行した調査報告書(QYR20AP00990)
◆英語タイトル:Global Heparin Sodium Injection Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00990
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ヘパリンナトリウム注射の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ヘパリンナトリウム注射のグローバル市場動向、メーカー別競争状況、種類別市場規模(1,000USP単位/mL、5,000USP単位/mL、10,000USP単位/mL)、用途別市場規模(静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気除細動、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ヘパリンナトリウム注射の種類別市場2015-2026:1,000USP単位/mL、5,000USP単位/mL、10,000USP単位/mL
・ヘパリンナトリウム注射の用途別市場2015-2026:静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気除細動、その他
・ヘパリンナトリウム注射の北米市場分析
・ヘパリンナトリウム注射のアジア市場分析
・ヘパリンナトリウム注射の中南米市場分析
・ヘパリンナトリウム注射の中東・アフリカ市場分析
・関連企業情報:Shenzhen Hepalink、Bioibérica、Nanjing King-friend、Pfizer、Dongcheng Biochemicals、Changzhou Qianhong Bio-pharma、Changshan Biochemical、Pharma Action、Baxter、Dongying Tiandong Pharmaceutical、Opocrin、Aspen Oss、Xinbai Pharmaceuticals、Yino Pharma Limited、Sichuan Deebio
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.In 2019, the global Heparin Sodium Injection market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Heparin Sodium Injection.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Heparin Sodium Injection market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Heparin Sodium Injection market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Heparin Sodium Injection market. Readers of the report can become informed about current and future trends of the global Heparin Sodium Injection market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Heparin Sodium Injection markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Heparin Sodium Injection market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Heparin Sodium Injection market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Heparin Sodium Injection market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Heparin Sodium Injection market is segmented into
1,000 USP Units / mL
5,000 USP Units / mL
10,000 USP Units / mL

Market Segment by Application, the Heparin Sodium Injection market is segmented into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Shenzhen Hepalink
Bioibérica
Nanjing King-friend
Pfizer
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio

The study objectives are:
To analyze and research the global Heparin Sodium Injection status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Heparin Sodium Injection manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Heparin Sodium Injection are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Heparin Sodium Injection Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Heparin Sodium Injection Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 1,000 USP Units / mL
1.3.3 5,000 USP Units / mL
1.3.4 10,000 USP Units / mL
1.4 Market Segment by Application
1.4.1 Global Heparin Sodium Injection Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Treatment of Venous Thromboembolism
1.4.3 Complications of Pregnancy
1.4.4 Cardioversion of Atrial Fibrillation/Flutter
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Heparin Sodium Injection Revenue (2015-2026)
2.1.1 Global Heparin Sodium Injection Revenue (2015-2026)
2.1.2 Global Heparin Sodium Injection Sales (2015-2026)
2.2 Heparin Sodium Injection Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Heparin Sodium Injection Sales by Regions (2015-2020)
2.2.2 Global Heparin Sodium Injection Revenue by Regions (2015-2020)
2.3 Global Top Heparin Sodium Injection Regions (Countries) Ranking by Market Size
2.4 Heparin Sodium Injection Industry Trends
2.4.1 Heparin Sodium Injection Market Top Trends
2.4.2 Market Drivers
2.4.3 Heparin Sodium Injection Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Heparin Sodium Injection Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Heparin Sodium Injection Manufacturers by Sales (2015-2020)
3.1.1 Global Heparin Sodium Injection Sales by Manufacturers (2015-2020)
3.1.2 Global Heparin Sodium Injection Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Heparin Sodium Injection Sales in 2019
3.2 Global Top Manufacturers Heparin Sodium Injection by Revenue
3.2.1 Global Heparin Sodium Injection Revenue by Manufacturers (2015-2020)
3.2.2 Global Heparin Sodium Injection Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Heparin Sodium Injection Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin Sodium Injection as of 2019)
3.4 Global Heparin Sodium Injection Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Heparin Sodium Injection Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Heparin Sodium Injection Market
3.7 Key Manufacturers Heparin Sodium Injection Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Heparin Sodium Injection Historic Market Review by Type (2015-2020)
4.1.2 Global Heparin Sodium Injection Sales Market Share by Type (2015-2020)
4.1.3 Global Heparin Sodium Injection Revenue Market Share by Type (2015-2020)
4.1.4 Heparin Sodium Injection Price by Type (2015-2020)
4.1 Global Heparin Sodium Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Heparin Sodium Injection Sales Forecast by Type (2021-2026)
4.2.3 Global Heparin Sodium Injection Revenue Forecast by Type (2021-2026)
4.2.4 Heparin Sodium Injection Price Forecast by Type (2021-2026)

5 Global Heparin Sodium Injection Market Size by Application
5.1 Global Heparin Sodium Injection Historic Market Review by Application (2015-2020)
5.1.2 Global Heparin Sodium Injection Sales Market Share by Application (2015-2020)
5.1.3 Global Heparin Sodium Injection Revenue Market Share by Application (2015-2020)
5.1.4 Heparin Sodium Injection Price by Application (2015-2020)
5.2 Global Heparin Sodium Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Heparin Sodium Injection Sales Forecast by Application (2021-2026)
5.2.3 Global Heparin Sodium Injection Revenue Forecast by Application (2021-2026)
5.2.4 Heparin Sodium Injection Price Forecast by Application (2021-2026)

6 North America
6.1 North America Heparin Sodium Injection Breakdown Data by Company
6.2 North America Heparin Sodium Injection Breakdown Data by Type
6.3 North America Heparin Sodium Injection Breakdown Data by Application
6.4 North America Heparin Sodium Injection Breakdown Data by Countries
6.4.1 North America Heparin Sodium Injection Sales by Countries
6.4.2 North America Heparin Sodium Injection Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Heparin Sodium Injection Breakdown Data by Company
7.2 Europe Heparin Sodium Injection Breakdown Data by Type
7.3 Europe Heparin Sodium Injection Breakdown Data by Application
7.4 Europe Heparin Sodium Injection Breakdown Data by Countries
7.4.1 Europe Heparin Sodium Injection Sales by Countries
7.4.2 Europe Heparin Sodium Injection Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Heparin Sodium Injection Breakdown Data by Company
8.2 Asia Pacific Heparin Sodium Injection Breakdown Data by Type
8.3 Asia Pacific Heparin Sodium Injection Breakdown Data by Application
8.4 Asia Pacific Heparin Sodium Injection Breakdown Data by Regions
8.4.1 Asia Pacific Heparin Sodium Injection Sales by Regions
8.4.2 Asia Pacific Heparin Sodium Injection Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Heparin Sodium Injection Breakdown Data by Company
9.2 Latin America Heparin Sodium Injection Breakdown Data by Type
9.3 Latin America Heparin Sodium Injection Breakdown Data by Application
9.4 Latin America Heparin Sodium Injection Breakdown Data by Countries
9.4.1 Latin America Heparin Sodium Injection Sales by Countries
9.4.2 Latin America Heparin Sodium Injection Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Heparin Sodium Injection Breakdown Data by Type
10.2 Middle East and Africa Heparin Sodium Injection Breakdown Data by Application
10.3 Middle East and Africa Heparin Sodium Injection Breakdown Data by Countries
10.3.1 Middle East and Africa Heparin Sodium Injection Sales by Countries
10.3.2 Middle East and Africa Heparin Sodium Injection Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Shenzhen Hepalink
11.1.1 Shenzhen Hepalink Corporation Information
11.1.2 Shenzhen Hepalink Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Shenzhen Hepalink Heparin Sodium Injection Products and Services
11.1.5 Shenzhen Hepalink SWOT Analysis
11.1.6 Shenzhen Hepalink Recent Developments
11.2 Bioibérica
11.2.1 Bioibérica Corporation Information
11.2.2 Bioibérica Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Bioibérica Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Bioibérica Heparin Sodium Injection Products and Services
11.2.5 Bioibérica SWOT Analysis
11.2.6 Bioibérica Recent Developments
11.3 Nanjing King-friend
11.3.1 Nanjing King-friend Corporation Information
11.3.2 Nanjing King-friend Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Nanjing King-friend Heparin Sodium Injection Products and Services
11.3.5 Nanjing King-friend SWOT Analysis
11.3.6 Nanjing King-friend Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Heparin Sodium Injection Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Dongcheng Biochemicals
11.5.1 Dongcheng Biochemicals Corporation Information
11.5.2 Dongcheng Biochemicals Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Dongcheng Biochemicals Heparin Sodium Injection Products and Services
11.5.5 Dongcheng Biochemicals SWOT Analysis
11.5.6 Dongcheng Biochemicals Recent Developments
11.6 Changzhou Qianhong Bio-pharma
11.6.1 Changzhou Qianhong Bio-pharma Corporation Information
11.6.2 Changzhou Qianhong Bio-pharma Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Products and Services
11.6.5 Changzhou Qianhong Bio-pharma SWOT Analysis
11.6.6 Changzhou Qianhong Bio-pharma Recent Developments
11.7 Changshan Biochemical
11.7.1 Changshan Biochemical Corporation Information
11.7.2 Changshan Biochemical Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Changshan Biochemical Heparin Sodium Injection Products and Services
11.7.5 Changshan Biochemical SWOT Analysis
11.7.6 Changshan Biochemical Recent Developments
11.8 Pharma Action
11.8.1 Pharma Action Corporation Information
11.8.2 Pharma Action Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Pharma Action Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Pharma Action Heparin Sodium Injection Products and Services
11.8.5 Pharma Action SWOT Analysis
11.8.6 Pharma Action Recent Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Baxter Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Baxter Heparin Sodium Injection Products and Services
11.9.5 Baxter SWOT Analysis
11.9.6 Baxter Recent Developments
11.10 Dongying Tiandong Pharmaceutical
11.10.1 Dongying Tiandong Pharmaceutical Corporation Information
11.10.2 Dongying Tiandong Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Products and Services
11.10.5 Dongying Tiandong Pharmaceutical SWOT Analysis
11.10.6 Dongying Tiandong Pharmaceutical Recent Developments
11.11 Opocrin
11.11.1 Opocrin Corporation Information
11.11.2 Opocrin Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Opocrin Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Opocrin Heparin Sodium Injection Products and Services
11.11.5 Opocrin SWOT Analysis
11.11.6 Opocrin Recent Developments
11.12 Aspen Oss
11.12.1 Aspen Oss Corporation Information
11.12.2 Aspen Oss Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Aspen Oss Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Aspen Oss Heparin Sodium Injection Products and Services
11.12.5 Aspen Oss SWOT Analysis
11.12.6 Aspen Oss Recent Developments
11.13 Xinbai Pharmaceuticals
11.13.1 Xinbai Pharmaceuticals Corporation Information
11.13.2 Xinbai Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Xinbai Pharmaceuticals Heparin Sodium Injection Products and Services
11.13.5 Xinbai Pharmaceuticals SWOT Analysis
11.13.6 Xinbai Pharmaceuticals Recent Developments
11.14 Yino Pharma Limited
11.14.1 Yino Pharma Limited Corporation Information
11.14.2 Yino Pharma Limited Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Yino Pharma Limited Heparin Sodium Injection Products and Services
11.14.5 Yino Pharma Limited SWOT Analysis
11.14.6 Yino Pharma Limited Recent Developments
11.15 Sichuan Deebio
11.15.1 Sichuan Deebio Corporation Information
11.15.2 Sichuan Deebio Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Sichuan Deebio Heparin Sodium Injection Products and Services
11.15.5 Sichuan Deebio SWOT Analysis
11.15.6 Sichuan Deebio Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Heparin Sodium Injection Sales Channels
12.2.2 Heparin Sodium Injection Distributors
12.3 Heparin Sodium Injection Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Heparin Sodium Injection Sales Forecast (2021-2026)
13.1.1 Global Heparin Sodium Injection Sales Forecast by Regions (2021-2026)
13.1.2 Global Heparin Sodium Injection Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Heparin Sodium Injection Sales Forecast (2021-2026)
13.2.2 North America Heparin Sodium Injection Revenue Forecast (2021-2026)
13.2.3 North America Heparin Sodium Injection Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Heparin Sodium Injection Sales Forecast (2021-2026)
13.3.2 Europe Heparin Sodium Injection Revenue Forecast (2021-2026)
13.3.3 Europe Heparin Sodium Injection Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Heparin Sodium Injection Sales Forecast (2021-2026)
13.4.2 Asia Pacific Heparin Sodium Injection Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Heparin Sodium Injection Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Heparin Sodium Injection Sales Forecast (2021-2026)
13.5.2 Latin America Heparin Sodium Injection Revenue Forecast (2021-2026)
13.5.3 Latin America Heparin Sodium Injection Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Heparin Sodium Injection Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Heparin Sodium Injection Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Heparin Sodium Injection Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Shenzhen Hepalink、Bioibérica、Nanjing King-friend、Pfizer、Dongcheng Biochemicals、Changzhou Qianhong Bio-pharma、Changshan Biochemical、Pharma Action、Baxter、Dongying Tiandong Pharmaceutical、Opocrin、Aspen Oss、Xinbai Pharmaceuticals、Yino Pharma Limited、Sichuan Deebio

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヘパリンナトリウム注射の世界市場2020-2026:1,000USP単位/mL、5,000USP単位/mL、10,000USP単位/mL(Global Heparin Sodium Injection Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。